Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

被引：38

作者：

Geisel, R

Schmitz, FJ

Fluit, AC

Labischinski, H

机构：

[1] Univ Dusseldorf, Inst Med Mikrobiol & Virol, D-40225 Dusseldorf, Germany

[2] Univ Utrecht, Med Ctr, Inst Med Microbiol, Utrecht, Netherlands

[3] Bayer AG, PH Res Antiinfect, D-5600 Wuppertal, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2001年 / 20卷 / 10期

关键词：

D O I：

10.1007/s100960100595

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In order to understand the mechanism(s) of the resistance/reduced susceptibility of Staphylococcus aureus to glycopeptide antibiotics, the current data on the modes of action of glycopeptides were reviewed. In addition, the different test systems for detecting vancomycin resistance and the clinical relevance of resistant Staphylococcus aureus were analyzed. Finally, strategies to prevent the nosocomial spread of these bacteria are presented, as are new therapeutic options.

引用

收藏

页码：685 / 697

页数：13

相关论文

共 68 条

[1] Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci [J].

Arthur, M ;

Depardieu, F ;

Reynolds, P ;

Courvalin, P .

MOLECULAR MICROBIOLOGY, 1996, 21 (01) :33-44

[2] Glycopeptide resistance in enterococci [J].

Arthur, M ;

Reynolds, P ;

Courvalin, P .

TRENDS IN MICROBIOLOGY, 1996, 4 (10) :401-407

[3] The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].

Austin, DJ ;

Kristinsson, KG ;

Anderson, RM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156

[4] Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: Efficacy of ampicillin-sulbactam [J].

Backo, M ;

Gaenger, E ;

Burkart, A ;

Chai, YL ;

Bayer, AS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2565-2568

[5] DEVELOPMENT OF INVITRO RESISTANCE TO GLYCOPEPTIDE ANTIBIOTICS - ASSESSMENT IN STAPHYLOCOCCI OF DIFFERENT SPECIES [J].

BIAVASCO, F ;

GIOVANETTI, E ;

MONTANARI, MP ;

LUPIDI, R ;

VARALDO, PE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :71-79

[6] Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].

Boyle-Vavra, S ;

Berke, SK ;

Lee, JC ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277

[7] A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates [J].

Boyle-Vavra, S ;

Labischinski, H ;

Ebert, CC ;

Ehlert, K ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :280-287

[8]

*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P765

[9] Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals [J].

Chesneau, O ;

Morvan, A ;

El Solh, N .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) :887-890

[10] Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].

Cui, LZ ;

Murakami, H ;

Kuwahara-Arai, K ;

Hanaki, H ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285

← 1 2 3 4 5 6 7 →